This forum is for questions about medical issues and research aspects of
Hepatitis C such as, questions about being newly diagnosed, questions about current treatments, information and participation in discussions about research studies and clinical trials related to Hepatitis. If you would like to communicate with other people who have been touched by Hepatitis, please visit our new
Hepatitis Social/Living with Hepatitis forum
My guess is you had it already, just didn't show up. Did you get tested for it before you started tx? I had tests done and they came out 'equivocal', which means I may have it, may not. So far, I don't think so. Do you work with chemicals or anything that may have been tough on your immune system? Again, I'm so sorry you have AIH.
I'd like to hear what others have to say on this.
So Sorry , and God Bless
Goldyn
I don’t know much about AIH. I do know that several members here have supposedly developed AIH because of IFN treatment. Have you been given a firm diagnosis? My limited understanding of this condition is that it’s more a diagnosis of elimination; not always cut and dry. Have you considered a second opinion? I think that with what you have at stake here, it might be in order. Boy, the implications are rather gloomy. With AIH being an absolute contraindication for IFN treatment, you’re currently left with few options, eh?
There is an AIH forum in England that I’ve heard mentioned here before, but I don’t have a link for it. I’ll flag Marri that posts in here occasionally, maybe she can offer some ideas.
I wish you luck; let us know how things progress-
Bill
Richard Sallie; Virology Journal 2005, 2:70) your hepatologist MAY be able to restart your HCV treatment. You may need stroids as well (that will increase the HCV levels), but if the interferon / ribavirin is effective it will probably overcome the effect of low-dose prednisolone. I have treated some patients with AIH / HCV combination effectively like this. It makes it harder, but not impossible; Don't Dispair!
Very interesting. By your comment above, are you a medical doctor? We could sure use one around here. Someone posted a link to the full-text study you referenced here recently:
http://www.virologyj.com/content/4/1/29
Thanks for stopping in. I hope you can return with more advice.
Bill
take it easy
-Mequila
The new generation of drugs and compounds should bring a lessened exposure to interferon either thru dose reduction or shortened dosing periods. It is theorized that the immune system may react to interferon and "over rev" and start targeting other body parts; not just our virus. I wonder...... if interferon is the culprit whether it might also be a reasonable thing to wait a few years until ones exposure to interferon could be mitigated while treating? The polymerase inhibitors may replace interferon. At the minimum IF Telaprevir pans out one may be able to treat in half the period currently dosed while facing roughly double the SVR rate. It's still too early to be able to tell about what to expect with treatments but if they live up to the promise that a few show you may very well be able to treat, cure the HCV, attain the SVR and then regulate the AIH.
As AIH becomes better understood you may also find that they may develop better means of regulating the disease. I just wonder if you should throw more "fuel on the fire" through more exposure to interferon when shorter or better treatments seem to be on the horizon. We may not hear about all the hazards of current TX until after improved treatments occur. I believe that I have heard that some doctors are able to moderate the balance of both treating HCV while fighting the results of AIH but again, the optimal results of TX are only 40-50% at best for most of us. Surely the SVR rates will drop when steroids are added to the mix when treating HCV. Might the results of AIH be the greater risk to you now than the HCV? Might a new round of TX exacerbate your AIH?
Don't give up. Pam (PLN) cleared the virus in 4 days with Telaprevir. MREmeet also cleared the virus in the same trial inspite starting treatment, stopping treatment (if memory serves me right) and then restarting with reduced dosages and with steroids. I agree that you can beat this virus. The question may be in part whether to attack it now or in a few years with a different form of treatment.
best wishes,
Willy
Welcome to the Forum and thanks for taking the time to offer your comments and suggestions.
Wyntre
best,
willy
Thanks for your take on this subject. Your thoughts are well considered and delivered; I’ve read some of you comments here in the past, and find them quite informative.
Autoimmune disorders are a scary subject indeed. Our endogenous immune system is an incredibly complex and powerful mechanism; it makes our current efforts at viral control/eradication seem primitive, huh? The thought of something like this running amuck is … ahem… to be highly respected at minimum.
I fully agree that there is so much we don’t know about this disease and its concomitant treatment. You appear to be leaning toward the ‘finesse’ approach. I’m assuming that your current histology supports your position. This seems like a very reasonable conclusion, especially for someone that has minimal damage.
Unfortunately, I don’t feel as though I have the luxury of time to exercise that option. As an F 3-4, I’m currently using the “sledgehammer approach”, and treating off-label in terms of both dosage and duration in an effort to achieve long-term viral response or possibly stave off further progression (I treated for 13 months previously and promptly relapsed).
Interestingly enough, I’ve been so engulfed with the current SOC, that I really haven’t followed the advances in the PI’s as closely as many in here. Although the preliminary news sounds encouraging, I was surprised to hear you mention the concept of PI’s as a possible stand-alone Tx. My understanding is that IFN will remain *at minimum* as an adjunct to PI’s, necessary because of escape variant rate when PI’s are used as monotherepy. If you’ve heard news to the contrary, would you mind passing it along?
Funny, I’m also starting to understand the role that philosophy plays in the decision process. Although they can’t be qualified or quantified, weighing in on such issues as quality of life, burden to society, and other equally important topics must be considered as well. Tough decisions, huh?
Well, I suppose I’m done with my ramble for now. Thanks again for adding your thoughts to this forum; and if you find time, I’d be interested to hear where you stand with liver damage, treatment efforts, etc.
Take good care—
Bill
you wrote:
" I was surprised to hear you mention the concept of PI’s as a possible stand-alone Tx. "
I didn't think I wrote that exactly but I did mention that Polymerase inhibitors may end up replacing Interferon (if all goes well some 3-5 years possibly in the future) Vertex maintains that they would like to combine a leading polymerase inhibitor (which one is unknown at this time) with their own protease inhibitor (Telaprevir) and they theorize that at some point down the road they may replace the current SOC. I believe that Sherring-Plough is engaged in this very thing right now. All that is looking down the road quite a piece and assumes that TVR is approved. : ) That is also a tad off the subject matter of this thread.
you wrote;
" My understanding is that IFN will remain *at minimum* as an adjunct to PI’s, necessary because of escape variant rate when PI’s are used as monotherepy. If you’ve heard news to the contrary, would you mind passing it along?"
No, we see or understand it exactly the same and I regret if my wording was imprecise on the subject. Other than that it is probably true for any form of current monotherapy.
Thanks for the kind words and I'm sure we'll have time to compare more notes in the future (it's after midnight and got to go to work in the AM) : ) As much as anyone else here I just try to read and understand. : )
I just butted in to try to echo that an SVR is not out of the picture for sass_blue.
best,
willy
"The polymerase inhibitors may replace interferon."
Protease inhibitors are what may replace or minimise the use of interferons whereas the polymerase inhibitors may end up replacing ribiviren. Vertex's Telaprevir is a protease inhibitor. While Telaprevir is still in trials and is not being tested to replace interferon the trials results are showing that treatment time (and therefore exposure to interferon) and may be greatly reduced in the near future also while showing increased SVR rates. My wording WAS both incorrect and imprecise. My basic premise holds true; SVR is attainable in spite of AIH and may become even more attainable in the relatively near future. The question remains as to whether to treat now or wait. There are trade-offs and gambles with either solution.
Thanks for the heads up; I didn't notice it last night.
best,
Willy